Edgewise Therapeutics (EWTX) Earnings Date, Estimates & Call Transcripts $14.38 -2.17 (-13.09%) Closing price 05/6/2025 03:59 PM EasternExtended Trading$14.09 -0.28 (-1.98%) As of 05:15 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Edgewise Therapeutics Earnings Summary Upcoming Earnings DateMay. 8Before Market OpensEstimatedConsensus EPS (Mar. 3) -$0.39 Actual EPS (Mar. 3) -$0.42 Missed By -$0.03 Edgewise Therapeutics issued Q4 2024 earnings on March 3, 2025, reporting an EPS of -$0.42, which missed the consensus estimate of -$0.39 by $0.03. With a trailing EPS of -$1.45, Edgewise Therapeutics' earnings are expected to decrease next year, from ($1.45) to ($1.86) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings Report Annual Report (10-K) Press Release (8-K)EWTX Upcoming EarningsEdgewise Therapeutics' Q1 2025 earnings is scheduled for Thursday, May 8, 2025, with a conference call scheduled at 9:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q1 2025 Earnings ReportPowered by Get Edgewise Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Edgewise Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataEWTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Edgewise Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.44-$0.40-$0.42Q2 20251-$0.49-$0.49-$0.49Q3 20251-$0.51-$0.51-$0.51Q4 20251-$0.55-$0.55-$0.55 FY 2025 5 -$1.99 -$1.95 -$1.97 Q1 20261-$0.52-$0.52-$0.52Q2 20261-$0.55-$0.55-$0.55Q3 20261-$0.58-$0.58-$0.58Q4 20261-$0.60-$0.60-$0.60 Edgewise Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/8/2025(Estimated)-------3/3/2025Q4 2024-$0.39-$0.42 -$0.03-$0.42--11/7/2024Q3 2024-$0.37-$0.36+$0.01-$0.36--8/8/2024--$0.36-$0.34+$0.02-$0.34--5/9/2024Q1 2024-$0.39-$0.33+$0.06-$0.33--2/22/2024Q4 2023-$0.44-$0.47 -$0.03-$0.47--11/9/2023Q3 2023-$0.40-$0.41 -$0.01-$0.41--8/10/2023Q2 2023-$0.41-$0.34+$0.07-$0.34--5/11/2023Q1 2023-$0.37-$0.36+$0.01-$0.36-- Edgewise Therapeutics Earnings - Frequently Asked Questions When is Edgewise Therapeutics's earnings date? Edgewise Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 8th, 2025 based off last year's report dates. Learn more on EWTX's earnings history. Did Edgewise Therapeutics beat their earnings estimates last quarter? In the previous quarter, Edgewise Therapeutics (NASDAQ:EWTX) missed the analysts' consensus estimate of ($0.39) by $0.03 with a reported earnings per share (EPS) of ($0.42). Learn more on analysts' earnings estimate vs. EWTX's actual earnings. How much profit does Edgewise Therapeutics generate each year? Edgewise Therapeutics (NASDAQ:EWTX) has a recorded net income of -$100.16 million. EWTX has generated -$1.45 earnings per share over the last four quarters. What is Edgewise Therapeutics's EPS forecast for next year? Edgewise Therapeutics's earnings are expected to decrease from ($1.45) per share to ($1.86) per share in the next year. More Earnings Resources from MarketBeat Related Companies Legend Biotech Earnings Results Sarepta Therapeutics Earnings Results ADMA Biologics Earnings Results Blueprint Medicines Earnings Results Verona Pharma Earnings Results Nuvalent Earnings Results Axsome Therapeutics Earnings Results Grifols Earnings Results Cytokinetics Earnings Results Krystal Biotech Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Palantir Stock Drops Despite Stellar Earnings: What's Next?Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?Is Reddit Stock a Buy, Sell, or Hold After Earnings Release?Warning or Opportunity After Super Micro Computer's EarningsAmazon Earnings: 2 Reasons to Love It, 1 Reason to Be CautiousRocket Lab Braces for Q1 Earnings Amid Soaring ExpectationsMeta Takes A Bow With Q1 Earnings - Watch For Tariff Impact in Q2 This page (NASDAQ:EWTX) was last updated on 5/7/2025 by MarketBeat.com Staff From Our Partners3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredWhat President Trump’s Executive Order 14154 means for your moneyNearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edgewise Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Edgewise Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy EWTX Stock Free EWTX Stock Alerts